Skip to main content

Table 1 Descriptive statistics for HPV vaccine completion defined as completion of the 3-dose series within 12 months

From: Associations between insurance-related affordable care act policy changes with HPV vaccine completion

 

Females

Males

N

%

% series completed

Unadjusted OR

(95% CI)

Adjusteda OR (95% CI)

N

%

% series completed

Unadjusted OR

(95% CI)

Adjusteda OR (95% CI)

Age of first dose (years)

 9–14

96,702

49.7

30.8

1

1

72,071

38.2

29.7

1

1

 15–18

56,407

29.0

26.8

0.83 (0.81–0.84)

0.79 (0.77–0.81)

87,336

46.2

28.6

0.95 (0.93–0.97)

0.86 (0.85–0.88)

 19–26

41,298

21.2

21.1

0.60 (0.59–0.62)

0.58 (0.56–0.59)

29,483

15.6

21.9

0.66 (0.64–0.68)

0.60 (0.58–0.62)

Insurance type

 Medicaid

28,827

14.8

17.6

1

1

22,588

12.0

17.8

1

1

 Private

165,580

85.2

29.3

1.94 (1.88–2.01)

2.60 (2.08–3.24)

166,302

88.0

29.4

1.93 (1.88–2.00)

1.93 (1.86–2.01)

Year of first dose

 2009b

3565

1.8

21.7

1

1

 2010

11,397

5.9

28.2

1.42 (1.29–1.55)

1.42 (1.29–1.56)

 2011

28,463

14.6

26.8

1.32 (1.22–1.44)

0.94 (0.83–1.07)

6484

3.4

31.8

1

1

 2012

59,371

30.5

32.6

1.74 (1.61–1.89)

1.14 (1.01–1.30)

74,231

39.3

34.8

1.15 (1.09–1.21)

1.09 (1.04–1.16)

 2013

64,134

33.0

22.2

1.03 (0.95–1.21)

0.62 (0.55–0.70)

78,172

41.4

21.4

0.58 (0.55–0.62)

0.52 (0.49–0.55)

 2014b

27,477

14.1

30.5

1.59 (1.46–1.72)

0.75 (0.65–0.86)

30,003

15.9

27.5

0.81 (0.77–0.86)

0.60 (0.55–0.65)

State

 Massachusetts

136,351

70.1

29.2

1

1

151,877

80.4

29.5

1

1

 Maine

24,761

12.7

24.4

0.78 (0.76–0.81)

0.76 (0.73–0.78)

15,160

8.0

19.3

0.57 (0.55–0.60)

0.59 (0.56–0.61)

 New Hampshire

33,295

17.1

23.2

0.73 (0.71–0.75)

0.67 (0.65–0.69)

21,853

11.6

23.6

0.74 (0.71–0.76)

0.72 (0.70–0.75)

  1. Abbreviations: CI, confidence interval; HPV, human papillomavirus; OR, odds ratio
  2. a Models were adjusted for all variables
  3. b Partial study year